Drug recall

Apheresis Platelets, Leukocytes Reduced

FDA recall event 82417 · Class II · The American National Red Cross - Southern Region

Key facts

Event ID 82417
Recall numbers B-0434-2019
Recalling firm The American National Red Cross - Southern Region
Product type Biologics
Products Apheresis Platelets, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Apheresis products, in which the WBC count was not performed, were distributed.
Initiation date Jan 30, 2019
Report date Mar 27, 2019
Termination date Mar 20, 2019
City Douglasville
State GA
Country United States
FEI number 1073000

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls